Comind to raise $60M series B led by Plural, joined by Angelini, LocalGlobe, Octopus Ventures, Crane Venture Partners, BACKED VC and Entrepreneurs First.
09 October 2025
09 October 2025
Total investments received (USD): 102.5M
Round value (USD): 60M
Company: CoMind
Related deals
Trogenix raised €80m in Series A led by IQ Capital, joined by 4Bio, Cancer Research Horizons, Brain Tumour Fund, Eli Lilly, Meltwind, LongeVC and Calculus
Investments
01 October 2025
Omnea raised $50m in Series B funding co-led by Insight Partners and Khosla Ventures, joined by Accel, Point Nine, First Round Capital, and Prosus.
Investments
05 September 2025
Attio raised €44 million Series B round led by GV (Google Ventures), joined by existing investors Redpoint Ventures, 01A, Point Nine, and Balderton Capital.
Investments
10 August 2025
Charm Therapeutics raised $80M Series B round co-led by New Enterprise Associates and SR One, w/ OrbiMed, F-Prime Capital, Khosla Ventures, and NVIDIA
Investments
02 August 2025
Ultromics raised $55 million through in a Series C round co-led by L&G, Allegis Capital, and Lightrock.
Investments
21 July 2025
Belgium
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Lithuania
Norway
Sweden
France
Ireland
Portugal
Spain